北京阳光诺和药物研究股份有限公司 关于股票回购增持借款展期的公告

Group 1 - The company announced a share repurchase plan to buy back its issued A-shares, with a total funding amount between RMB 50 million and RMB 100 million [1] - As of March 6, 2025, the company has repurchased a total of 2.721783 million shares, accounting for 2.43% of the total share capital, with a total payment of approximately RMB 99.97 million [2] - The company extended the loan agreement with China Postal Savings Bank from 12 months to 24 months, while the loan purpose remains unchanged [3]